Lv1
38 积分 2025-03-13 加入
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
1天前
待确认
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
12天前
已完结
Combined gastric and colorectal cancer endoscopic screening may be cost-effective in Europe with the implementation of artificial intelligence: an economic evaluation
18天前
已完结
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses
1个月前
已完结
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
1个月前
已完结
Response to telitacicept in systemic lupus erythematosus patients: a real‐world, single‐center observational study in China
1个月前
已完结
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study
1个月前
已完结
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
3个月前
已完结
The Efficacy and Safety of Unfixed and Fixed Combinations of Latanoprost and Other Antiglaucoma Medications
5个月前
已完结
皖公网安备34019202002308